- Preview Available
- Scholarly Journal
Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines
Liu, Yang; Lu, Jie; Zhang, Zhimeng; Zhu, Lin; Dong, Shicai
; et al.
Cell Death and Disease; London Vol. 8, Iss. 8, (Aug 2017): n/a.
DOI:10.1038/cddis.2017.396
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.